✦ LIBER ✦

PMH32 THE IMPACT OF DULOXETINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER ON THE QUALITY OF LIFE IN DEPRESSION SCALE

✍ Scribed by RL Robinson; RL Obenchain; TW Croghan

Book ID: 119592024
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 62 KB
Volume: 5
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)61097-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH21 BUDGET IMPACT ANALYSIS OF DULOXETI

PMH21 BUDGET IMPACT ANALYSIS OF DULOXETINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER

✍ B Gwiosda; J Rutkowski; P Rys; R Plisko; M Wladysiuk; M Cel; P Mierzejewski; W B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Duloxetine for the Treatment of Major De

Duloxetine for the Treatment of Major Depressive Disorder in Older Patients

✍ Nelson, J. Craig; Wohlreich, Madelaine M.; Mallinckrodt, Craig H.; Detke, Michae 📂 Article 📅 2005 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 117 KB

PMH45 COST EFFECTIVENESS OF DULOXETINE C

PMH45 COST EFFECTIVENESS OF DULOXETINE COMPARED WITH VENLAFAXINE-XR IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

✍ M Van Baardewijk; PM Vis; T Einarson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

The impact of treatment on quality of li

The impact of treatment on quality of life in major depressive disorder (MDD) and generalized anxiety disorder (GAD)

✍ K. Demyttenaere 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 43 KB

PMH53 ASSESSING THE IMPACT OF MAJOR DEPR

PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING: DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALE

✍ Lançon, C.; DiBenedetti, D.B.; Lewis, S.; Davis, K.; Danchenko, N.; François, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

The combination of duloxetine and buprop

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission